MétaCan
Menu
Back to cohort
Record W2176156606 · doi:10.1371/journal.pone.0133907

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome?

2015· review· en· W2176156606 on OpenAlexaff
Valérie Devauchelle‐Pensec, Jacques‐Eric Gottenberg, Sandrine Jousse‐Joulin, Jean‐Marie Berthelot, Aleth Perdriger, É. Hachulla, P.Y. Hatron, Xavier Puéchal, Véronique Le Guern, Jean Sibilia, Laurent Chiche, Vincent Goëb, Olivier Vittecoq, C. Larroche, A.L. Fauchais, Gilles Hayem, Jacques Morel, Charles Zarnitsky, Jean‐Jacques Dubost, Philippe Dieudé, Jacques‐Olivier Pers, Divi Cornec, Raphaèle Séror, Xavier Mariette, Emmanuel Nowak, Alain Saraux

Bibliographic record

VenuePLoS ONE · 2015
Typereview
Languageen
FieldMedicine
TopicSalivary Gland Disorders and Functions
Canadian institutionsHotel Dieu Hospital
Fundersnot available
KeywordsMedicineClinical endpointVisual analogue scalePlaceboInternal medicineCohortPopulationSample size determinationRandomized controlled trialPhysical therapyPathology

Abstract

fetched live from OpenAlex

OBJECTIVE: The goal of this study was to determine how the choice of the primary endpoint influenced sample size estimates in randomised controlled trials (RCTs) of treatments for primary Sjögren's syndrome (pSS). METHODS: We reviewed all studies evaluating biotechnological therapies in pSS to identify their inclusion criteria and primary endpoints. Then, in a large cohort (ASSESS), we determined the proportion of patients who would be included in RCTs using various inclusion criteria sets. Finally, we used the population of a large randomised therapeutic trial in pSS (TEARS) to assess the impact of various primary objectives and endpoints on estimated sample sizes. These analyses were performed only for the endpoints indicating greater efficacy of rituximab compared to the placebo. RESULTS: We identified 18 studies. The most common inclusion criteria were short disease duration; systemic involvement; high mean visual analogue scale (VAS) scores for dryness, pain, and fatigue; and biological evidence of activity. In the ASSESS cohort, 35 percent of patients had recent-onset disease (lower than 4 years), 68 percent systemic manifestations, 68 percent high scores on two of three VASs, and 52 percent biological evidence of activity. The primary endpoints associated with the smallest sample sizes (nlower than 200) were a VAS dryness score improvement higher to 20 mm by week 24 or variable improvements (10, 20, or 30 mm) in fatigue VAS by week 6 or 16. For patients with systemic manifestations, the ESSDAI change may be the most logical endpoint, as it reflects all domains of disease activity. However, the ESSDAI did not improve significantly with rituximab therapy in the TEARS study. Ultrasound score improvement produced the smallest sample size estimate in the TEARS study. CONCLUSION: This study provides valuable information for designing future RCTs on the basis of previously published studies. Previous RCTs used inclusion criteria that selected a small part of the entire pSS population. The endpoint was usually based on VASs assessing patient complaints. In contrast to VAS dryness cut-offs, VAS fatigue cut-offs did not affect estimated sample sizes. SGUS improvement produced the smallest estimated sample size. Further studies are required to validate standardised SGUS modalities and assessment criteria. Thus, researchers should strive to develop a composite primary endpoint and to determine its best cut-off and assessment time point.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.295
metaresearch head score (Gemma)0.430
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.705
Threshold uncertainty score0.869

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2950.430
Meta-epidemiology (narrow)0.0020.002
Meta-epidemiology (broad)0.0130.012
Bibliometrics0.0030.002
Science and technology studies0.0020.004
Scholarly communication0.0050.010
Open science0.0020.002
Research integrity0.0110.005
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.204
GPT teacher head0.340
Teacher spread0.136 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designTheoretical or conceptual
DomainMethods
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations22
Published2015
Admission routes1
Has abstractyes

Explore more

Same venuePLoS ONESame topicSalivary Gland Disorders and FunctionsFrench-language works237,207